Dana-Farber at Milford

Milford, Massachusetts 01757

1 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor Positive Breast Cancer, Invasive Carcinoma of the Breast, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Micrometastasis Breast Cancer, Monoclonal Gammopathy of Undetermined Significance, Node Negative Breast Cancer, Other Cancer, Smoldering Multiple Myeloma, Stage II Breast Cancer

Studies at this site

• ATEMPT 2.0: Adjuvant T-DM1 vs TH — Recruiting now
• A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer — Running, not enrolling
• Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma — Running, not enrolling
• MARGetuximab Or Trastuzumab (MARGOT) — Running, not enrolling
• Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation — Completed
• Improving Informed Consent for Palliative Chemotherapy — Completed
• Cisplatin + RT for Triple Negative Breast Cancer — Completed